经皮腔内颈动脉血管成形与支架植入术治疗颈内动脉狭窄性脑梗死患者的疗效

doi:10.3969/j.issn.1671-7171.2026.07.009

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1240 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To explore the efficacy of percutaneous transluminal carotid angioplasty and stenting (PTCAS) in the treatment of patients with internal carotid artery stenotic cerebral infarction. 【Methods】 A total of 100 patients with internal carotid artery stenotic cerebral infarction admitted from June 2023 to June 2025 were randomly divided into the control group and the observation group, with 50 cases in each group. The control group received simple carotid artery stenting, while the observation group was treated with PTCAS. Perioperative indicators, hemorheological parameters including fibrinogen (FIB), platelet aggregation rate (PAgT) and hematocrit (HCT), serological indicators including malondialdehyde (MDA), N-terminal pro-B-type natriuretic peptide (NT-proBNP) and osteopontin (OPN), neurological function assessed by National Institutes of Health Stroke Scale (NIHSS), activity of daily living evaluated by Barthel Index (BI), and the incidence of complications were compared between the two groups before and after treatment. 【Results】 The operation time of the observation group was longer than that of the control group, while the time to get out of bed and hospital stay were shorter than those of the control group (all P<0.05). After treatment, the levels of FIB, PAgT, HCT, MDA, NT-proBNP and OPN in the observation group were significantly lower than those in the control group (P<0.05). The NIHSS score of the observation group was lower, the BI score was higher, and the total incidence of complications was lower compared to the control group (P<0.05). 【Conclusion】 For patients with internal carotid artery stenotic cerebral infarction, PTCAS can reduce the incidence of complications, improve hemorheological indexes, promote the recovery of neurological function, and enhance patients' quality of life.

Key words： Brain Infarction Carotid Stenosis Angioplasty Stents

Received: 21 July 2025

PACS:

R743.33

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WEI Liren

Cite this article:

WEI Liren. Efficacy of Percutaneous Transluminal Carotid Angioplasty and Stenting in Treatment of Patients with Internal Carotid Artery Stenotic Cerebral Infarction[J]. JOURNAL OF CLINICAL RESEARCH, 2026, 43(7): 1087-1089.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2026.07.009 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2026/V43/I7/1087

[1] 李兰芳,刘振,冯蕾孟,等.急性脑梗死伴房颤患者抗凝治疗现状及影响因素分析[J].实用药物与临床,2022, 25(6):507-511.
[2] 秦英,王伟,张淑萍.进展性脑梗死MRI预测指标的研究进展[J].临床神经病学杂志, 2022, 35(4):304-307.
[3] 陈浩,黄炎,杜波,等. 血管介入术对症状性颅内前循环动脉狭窄病人再狭窄及脑血流动力学影响的临床研究[J].立体定向和功能性神经外科杂志,2025,38(2):101-106.
[4] 王晓禹. Solitaire AB支架取栓联合阿替普酶静脉溶栓对急性脑梗死患者mTICI分级及脑血流动力学的影响[J].中国医疗器械信息,2026,32(5):89-91.
[5] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志,2015,48(4):246-257.
[6] 谈颂,常思远,宋波,等. 早期改良美国国立卫生研究院卒中量表评分对缺血性卒中预后的预测作用[J].中华神经科杂志,2012,45(3):154-157.
[7] 张雅静,张小兰,马延爱,等. Barthel指数量表应用于急性脑卒中患者生活能力测量的信度研究[J].中国护理管理,2007,7(5):30-32.
[8] 见秀丽,张敏,恽文伟. 急性脑梗死患者单侧颈内动脉狭窄与血管周围间隙扩大不对称分布的相关性[J].中华医学杂志,2023,103(3):178-185.
[9] 李阔,王丽轩,张传锁,等. 急性分水岭脑梗死血清KLF4、OLFM-2水平及其与血管内支架植入术后再狭窄的关系[J].局解手术学杂志,2025,34(12):1091-1095.
[10] 王临风,周一凡,谢满意,等. 高压氧联合支架植入术治疗脑梗死合并颅外段血管狭窄的疗效分析[J].川北医学院学报,2025,40(10):1249-1252.
[11] 马永明,陈美丽,包蕾,等. 颈内动脉支架植入对次全闭塞脑梗死亚急性期患者血流灌注及神经功能的影响[J].中国现代医学杂志,2025,35(14):12-18.
[12] 赵剑,左姗姗,张亚辉,等. 颈动脉支架植入术对合并腔隙性脑梗死的轻度血管性认知障碍患者认知功能影响[J].中华保健医学杂志,2022,24(3):204-207.
[13] 王泽庆,文家智,张泽奎,等. 丹参多酚酸联合重组人组织型纤溶酶原激活物治疗急性大面积脑梗死的临床效果及对近期预后的影响[J].实用医院临床杂志,2024,21(5):100-104.
[14] 申猛.支架取栓术联合血栓抽吸术治疗急性脑梗死患者的效果[J].中国民康医学,2023,35(4):36-38.

[1]	. [J]. JOURNAL OF CLINICAL RESEARCH, 2026, 43(7): 1166-1169.